Regulatory considerations for development of bioanalytical assays for biotechnology products.
about
Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis.Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology PerspectiveStrategic selection and development of immunogenicity binding methods.When assay format matters: a case study on the evaluation of three assay formats to support a clinical pharmacokinetic study.Carbon paste electrode modified with cuo-nanoparticles as a probe for square wave voltammetric determination of atrazine.A generic template for automated bioanalytical ligand-binding assays using modular robotic scripts in support of discovery biotherapeutic programs.
P2860
Q30716340-1485C2E7-A3F0-4450-911D-B7C5B5B88892Q35929084-2010926D-CF61-426A-A209-31DEE2D16391Q36653930-A477D9DA-33CC-4517-91CF-06B33ACD9208Q38026065-2D239B32-04B6-4966-92EE-B88837D15EECQ41150488-86546C61-11AC-4097-96C3-27031281A4B3Q41997017-71D32302-1678-4A57-B921-EC6730D9291EQ44767432-240154E4-2EF5-41B1-ACC2-3C614AF36D81
P2860
Regulatory considerations for development of bioanalytical assays for biotechnology products.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Regulatory considerations for ...... ys for biotechnology products.
@en
Regulatory considerations for ...... ys for biotechnology products.
@nl
type
label
Regulatory considerations for ...... ys for biotechnology products.
@en
Regulatory considerations for ...... ys for biotechnology products.
@nl
prefLabel
Regulatory considerations for ...... ys for biotechnology products.
@en
Regulatory considerations for ...... ys for biotechnology products.
@nl
P2860
P356
P1433
P1476
Regulatory considerations for ...... ys for biotechnology products.
@en
P2093
Marjorie A Shapiro
Patrick G Swann
P2860
P304
P356
10.4155/BIO.11.27
P577
2011-03-01T00:00:00Z